This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Sembiosys Genetics, Inc., Uti Limited Partnership. Active years: 2009-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2009-2010
Title: Cory Lee Nykiforuk: Innovator in Plant Biotechnology
Introduction
Cory Lee Nykiforuk is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of plant biotechnology, particularly in the production of apolipoproteins and insulin through transgenic plants. With a total of two patents to his name, Nykiforuk's work has the potential to impact the agricultural and pharmaceutical industries.
Latest Patents
Nykiforuk's latest patents include innovative methods for the production of apolipoproteins in transgenic plants. These methods describe the expression of apolipoproteins in plants, which can lead to advancements in biotechnology. Additionally, he has developed methods for the production of insulin in plants. This approach allows for the commercial production of human insulin via transgenic expression in plant seeds, achieving insulin accumulation levels exceeding 0.1% of total cellular protein. The production in seeds offers advantages in storage and shipment, as insulin retains its activity upon extraction from stored seeds.
Career Highlights
Throughout his career, Nykiforuk has worked with several companies, including Sembiosys Genetics, Inc. and Uti Limited Partnership. His experience in these organizations has contributed to his expertise in plant biotechnology and transgenic research.
Collaborations
Nykiforuk has collaborated with notable individuals in the field, including Maurice M. Moloney and Joseph Boothe. These collaborations have likely enhanced his research and development efforts in biotechnology.
Conclusion
Cory Lee Nykiforuk is a prominent inventor whose work in plant biotechnology has the potential to revolutionize the production of essential proteins like apolipoproteins and insulin. His innovative methods and collaborations highlight his significant contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile